Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas
Cannabis & Cannabinoid Research · 01.12.2023 · 8 (6) · 1140-1149
DOI: 10.1089/can.2022.0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, online erschienen am 04.12.2023. Verfasst von Christina N Wysota und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columb…. Hauptthemen laut MEDLINE: Cannabidiol. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NIDA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
Cannabidiol (CBD) has gained popularity in the United States, particularly among certain populations, including young adults. Thus, we examined (1) CBD product knowledge, perceptions, use, and use intentions among young adults and (2) correlates of use and use intentions.
Methods
We analyzed data from a Fall 2020 survey regarding tobacco and other substance use among 2464 young adults in 6 U.S. cities (M age =24.67; 57.4% female; 28.7% racial/ethnic minority). We used multinomial regression to identify correlates of use status (i.e., former [ever but no past 6 months] use vs. current [past 6 months] and never use, respectively), and linear regression to examine use intentions among never users.
Results
Around 51.4% reported ever use, and 32.0% reported current use. On average, participants perceived CBD as safe and effective for addressing pain, anxiety, and sleep (also prominent use motives: ∼40% to 60%, respectively). Use intentions were relatively high, particularly for edibles and topicals (also the most common use modes). Roughly one-fourth mistakenly believed that CBD products were required to be approved by U.S. Food and Drug Administration (24.9%), tested/proven safe (28.8%), and proven effective to be marketed for pain, anxiety, sleep, and so on. (27.2%). Compared to former users, never users perceived greater CBD-related risk ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
- Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California, USA.
- George Washington Cancer Center, George Washington University, Washington, District of Columbia, USA.
- Department of Health Policy and Behavioral Sciences, School of Public Health, Georgia State University, Atlanta, Georgia, USA.
ORCID-Profile: Carla J Berg
Förderung
- FIC NIH HHS
- NIDA NIH HHS
- NCI NIH HHS
- NIEHS NIH HHS
Zitieren
APA
Wysota, C. N., Henriksen, L., Romm, K. F., Duan, Z., Wang, Y., Huang, J., & Berg, C. J. (2023). Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas. Cannabis & Cannabinoid Research, 8(6), 1140-1149. https://doi.org/10.1089/can.2022.0029
Vancouver
Wysota CN, Henriksen L, Romm KF, Duan Z, Wang Y, Huang J, et al. Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas. Cannabis & Cannabinoid Research. 2023;8(6):1140-1149. doi:10.1089/can.2022.0029
BibTeX
@article{Wysota2023,
author = {Wysota, Christina N and Henriksen, Lisa and Romm, Katelyn F and Duan, Zongshuan and Wang, Yan and Huang, Jidong and Berg, Carla J},
title = {Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas},
journal = {Cannabis & Cannabinoid Research},
year = {2023},
volume = {8},
number = {6},
pages = {1140--1149},
doi = {10.1089/can.2022.0029}
}
EUVIMED